DXCM Q4 2024 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.1B+7.6% YoY

Gross Profit

$656M58.9% margin

Operating Income

$189M17.0% margin

Net Income

$152M13.6% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+12.0%

Cash Flow

Operating Cash Flow

$301M

Free Cash Flow

$177M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$6.5B

Total Liabilities

$4.4B

Stockholders' Equity

$2.1B

Cash & Equivalents

$606M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.0B	+7.6%
Gross Profit	$656M	$657M	-0.1%
Operating Income	$189M	$217M	-12.9%
Net Income	$152M	$256M	-40.8%